Comparison of nanogel drug carriers and their formulations with nucleoside 5′-triphosphates

Serguei V. Vinogradov, Ekta Kohli, Arin D. Zeman

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Purpose. The aim of the study is to synthesize and characterize nanogel carriers composed of amphiphilic polymers and cationic polyethylenimine for encapsulation and delivery of cytotoxic nucleoside analogs 5′- triphosphates (NTPs) into cancer cells. Methods. Nanogels were synthesized by a novel micellar approach and compared with carriers prepared by the emulsification/evaporation method. Complexes of nanogels with NTP were prepared; particle size and in vitro drug release were characterized. Resistance of the nanogel-encapsulated NTP to enzymatic hydrolysis was analyzed by ion-pair high-performance liquid chromatography. Binding to isolated cellular membranes, cellular accumulation and cytotoxicity were compared using breast carcinoma cell lines CL-66, MCF-7, and MDA-MB-231. In vivo biodistribution of the 3H-labeled NTP encapsulated in different types of nanogels was evaluated in comparison to the injected NTP alone. Results. Nanogels with a particle size of 100-300 nm in the unloaded form and less than 140 nm in the NTP-loaded form were prepared. An in vitro release of NTP was >50% during the first 24 h. Nanogel formulations ensured increased NTP drug stability against enzymatic hydrolysis as compared to the drug alone. Pluronic®-based nanogels NG(F68), NG(F127), NG(P85), and NGM(P123) demonstrated 2-2.5 times enhanced interaction with cellular membranes and association with various cancer cells compared to NG(PEG). Among them, NG(F68) and NG(F127) exhibited the lowest cytotoxicity. Injection of nanogel-formulated NTP significantly modulated the drug accumulation in different mouse organs. Conclusions. Nanogels composed of Pluronic® F68 and P123 were shown to display certain advanced properties compared to NG(PEG) as a drug delivery system for NTP analogs. Formulations of nucleoside analogs in active NTP form with these nanogels will improve the delivery of these cytotoxic drugs to cancer cells and the therapeutic potential of this anticancer chemotherapy.

Original languageEnglish (US)
Pages (from-to)920-930
Number of pages11
JournalPharmaceutical Research
Volume23
Issue number5
DOIs
StatePublished - May 1 2006

Fingerprint

Drug Carriers
Nucleosides
UCON 50-HB-5100
Cells
Poloxamer
Enzymatic hydrolysis
Pharmaceutical Preparations
Cytotoxicity
Particle Size
Polyethylene glycols
triphosphoric acid
NanoGel
Hydrolysis
Particle size
Drug Stability
Membranes
Polyethyleneimine
Neoplasms
Chemotherapy
Emulsification

Keywords

  • Breast cancer cells
  • Cellular association
  • Drug release
  • Nanogels
  • Organ biodistribution
  • Synthesis

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Comparison of nanogel drug carriers and their formulations with nucleoside 5′-triphosphates. / Vinogradov, Serguei V.; Kohli, Ekta; Zeman, Arin D.

In: Pharmaceutical Research, Vol. 23, No. 5, 01.05.2006, p. 920-930.

Research output: Contribution to journalArticle

Vinogradov, Serguei V. ; Kohli, Ekta ; Zeman, Arin D. / Comparison of nanogel drug carriers and their formulations with nucleoside 5′-triphosphates. In: Pharmaceutical Research. 2006 ; Vol. 23, No. 5. pp. 920-930.
@article{e10951cc1b2f4b15a26d64b83ad140e2,
title = "Comparison of nanogel drug carriers and their formulations with nucleoside 5′-triphosphates",
abstract = "Purpose. The aim of the study is to synthesize and characterize nanogel carriers composed of amphiphilic polymers and cationic polyethylenimine for encapsulation and delivery of cytotoxic nucleoside analogs 5′- triphosphates (NTPs) into cancer cells. Methods. Nanogels were synthesized by a novel micellar approach and compared with carriers prepared by the emulsification/evaporation method. Complexes of nanogels with NTP were prepared; particle size and in vitro drug release were characterized. Resistance of the nanogel-encapsulated NTP to enzymatic hydrolysis was analyzed by ion-pair high-performance liquid chromatography. Binding to isolated cellular membranes, cellular accumulation and cytotoxicity were compared using breast carcinoma cell lines CL-66, MCF-7, and MDA-MB-231. In vivo biodistribution of the 3H-labeled NTP encapsulated in different types of nanogels was evaluated in comparison to the injected NTP alone. Results. Nanogels with a particle size of 100-300 nm in the unloaded form and less than 140 nm in the NTP-loaded form were prepared. An in vitro release of NTP was >50{\%} during the first 24 h. Nanogel formulations ensured increased NTP drug stability against enzymatic hydrolysis as compared to the drug alone. Pluronic{\circledR}-based nanogels NG(F68), NG(F127), NG(P85), and NGM(P123) demonstrated 2-2.5 times enhanced interaction with cellular membranes and association with various cancer cells compared to NG(PEG). Among them, NG(F68) and NG(F127) exhibited the lowest cytotoxicity. Injection of nanogel-formulated NTP significantly modulated the drug accumulation in different mouse organs. Conclusions. Nanogels composed of Pluronic{\circledR} F68 and P123 were shown to display certain advanced properties compared to NG(PEG) as a drug delivery system for NTP analogs. Formulations of nucleoside analogs in active NTP form with these nanogels will improve the delivery of these cytotoxic drugs to cancer cells and the therapeutic potential of this anticancer chemotherapy.",
keywords = "Breast cancer cells, Cellular association, Drug release, Nanogels, Organ biodistribution, Synthesis",
author = "Vinogradov, {Serguei V.} and Ekta Kohli and Zeman, {Arin D.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1007/s11095-006-9788-5",
language = "English (US)",
volume = "23",
pages = "920--930",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Comparison of nanogel drug carriers and their formulations with nucleoside 5′-triphosphates

AU - Vinogradov, Serguei V.

AU - Kohli, Ekta

AU - Zeman, Arin D.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Purpose. The aim of the study is to synthesize and characterize nanogel carriers composed of amphiphilic polymers and cationic polyethylenimine for encapsulation and delivery of cytotoxic nucleoside analogs 5′- triphosphates (NTPs) into cancer cells. Methods. Nanogels were synthesized by a novel micellar approach and compared with carriers prepared by the emulsification/evaporation method. Complexes of nanogels with NTP were prepared; particle size and in vitro drug release were characterized. Resistance of the nanogel-encapsulated NTP to enzymatic hydrolysis was analyzed by ion-pair high-performance liquid chromatography. Binding to isolated cellular membranes, cellular accumulation and cytotoxicity were compared using breast carcinoma cell lines CL-66, MCF-7, and MDA-MB-231. In vivo biodistribution of the 3H-labeled NTP encapsulated in different types of nanogels was evaluated in comparison to the injected NTP alone. Results. Nanogels with a particle size of 100-300 nm in the unloaded form and less than 140 nm in the NTP-loaded form were prepared. An in vitro release of NTP was >50% during the first 24 h. Nanogel formulations ensured increased NTP drug stability against enzymatic hydrolysis as compared to the drug alone. Pluronic®-based nanogels NG(F68), NG(F127), NG(P85), and NGM(P123) demonstrated 2-2.5 times enhanced interaction with cellular membranes and association with various cancer cells compared to NG(PEG). Among them, NG(F68) and NG(F127) exhibited the lowest cytotoxicity. Injection of nanogel-formulated NTP significantly modulated the drug accumulation in different mouse organs. Conclusions. Nanogels composed of Pluronic® F68 and P123 were shown to display certain advanced properties compared to NG(PEG) as a drug delivery system for NTP analogs. Formulations of nucleoside analogs in active NTP form with these nanogels will improve the delivery of these cytotoxic drugs to cancer cells and the therapeutic potential of this anticancer chemotherapy.

AB - Purpose. The aim of the study is to synthesize and characterize nanogel carriers composed of amphiphilic polymers and cationic polyethylenimine for encapsulation and delivery of cytotoxic nucleoside analogs 5′- triphosphates (NTPs) into cancer cells. Methods. Nanogels were synthesized by a novel micellar approach and compared with carriers prepared by the emulsification/evaporation method. Complexes of nanogels with NTP were prepared; particle size and in vitro drug release were characterized. Resistance of the nanogel-encapsulated NTP to enzymatic hydrolysis was analyzed by ion-pair high-performance liquid chromatography. Binding to isolated cellular membranes, cellular accumulation and cytotoxicity were compared using breast carcinoma cell lines CL-66, MCF-7, and MDA-MB-231. In vivo biodistribution of the 3H-labeled NTP encapsulated in different types of nanogels was evaluated in comparison to the injected NTP alone. Results. Nanogels with a particle size of 100-300 nm in the unloaded form and less than 140 nm in the NTP-loaded form were prepared. An in vitro release of NTP was >50% during the first 24 h. Nanogel formulations ensured increased NTP drug stability against enzymatic hydrolysis as compared to the drug alone. Pluronic®-based nanogels NG(F68), NG(F127), NG(P85), and NGM(P123) demonstrated 2-2.5 times enhanced interaction with cellular membranes and association with various cancer cells compared to NG(PEG). Among them, NG(F68) and NG(F127) exhibited the lowest cytotoxicity. Injection of nanogel-formulated NTP significantly modulated the drug accumulation in different mouse organs. Conclusions. Nanogels composed of Pluronic® F68 and P123 were shown to display certain advanced properties compared to NG(PEG) as a drug delivery system for NTP analogs. Formulations of nucleoside analogs in active NTP form with these nanogels will improve the delivery of these cytotoxic drugs to cancer cells and the therapeutic potential of this anticancer chemotherapy.

KW - Breast cancer cells

KW - Cellular association

KW - Drug release

KW - Nanogels

KW - Organ biodistribution

KW - Synthesis

UR - http://www.scopus.com/inward/record.url?scp=33646875941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646875941&partnerID=8YFLogxK

U2 - 10.1007/s11095-006-9788-5

DO - 10.1007/s11095-006-9788-5

M3 - Article

C2 - 16715382

AN - SCOPUS:33646875941

VL - 23

SP - 920

EP - 930

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 5

ER -